《新股表現》CGII(01940.HK)高開24%報1.7元
CGII HLDGS(01940.HK)暗盤高開2.2%報1.4元獲承接,曾漲35%至1.85元,收1.67元高上市價22%;該股首掛報1.7元,較上市價1.37元,高24%,市前成交1,825萬股。
CGII主要經營管道工業氣體和液化工業氣體供應以及液化天然氣相關業務。根據弗若斯特沙利文報告,按收益計,CGII為2019年京津冀區域第二大工業氣體供應商。是次來港上市共發售3億股,其中10%公開發售獲9倍超購,認購一手中籤率僅10%;股份以招股範圍(1.37-1.77元)下限定價,料集資淨額約3.16億元,大部分用作採購及搬遷與中氣投(唐山)廠房發展有關空氣分離裝置。上市獨家保薦人光大證券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.